Bloom Energy stock is now up a whopping 89% in just two weeks, as of this writing. Several analysts turned bullish about Bloom Energy this week and raised their price targets on the stock. Notable ...

Elastic's management did raise its full-year guidance. It now expects 15% growth this year, compared to prior guidance of 14% growth. And investors might note that this isn't much of an increase. But ...

While the argument has merit, the price target looks ambitious. The $200 figure, offering 37% upside from recent prices, would put Boeing at a market cap of almost $150 billion. The Wall Street ...

It may not be the growth stock it once was, but there's still has plenty of fuel left in the tank.

On Tuesday, Needham & Co. analyst Chris Pierce launched coverage on both Archer and Joby, giving both buy ratings, with Pierce giving Joby 30% upside and Archer 100% upside. Needless to say, that big ...

At this point, you still have several weeks left to open a CD before the end of 2024. But do know that the longer you wait, the more you might risk losing out on a better rate. So if you're sure a CD ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

The world of pharmacenutical stocks has a lot to offer investors. With their resilience in the face of economic issues and ...

Not sure how to choose the right credit card? Check out my best tips after using more than 20 cards over the years.

Shop in stores instead of online for extra savings. Don't spend too much time at the front of the store, and never shop ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Shares of biotech Intellia Therapeutics ( NTLA 5.18%) are down by around 33% over the past 30 days, amid the publication of some new data from an early stage clinical trial on Nov. 16 and its ...